A groundbreaking study published in Radiology showcases the potential of ultra-high-resolution CT technology in transforming cardiac diagnosis. By delivering exceptional image quality and precise detection of coronary artery disease, this innovative approach opens doors for noninvasive screening in high-risk patients previously ineligible.
Read MoreThe WISE study sheds light on the crucial role of sex-specific left ventricular ejection fraction (LVEF) in women’s heart health. High LVEF levels (>65%) were associated with significantly lower rates of mortality and nonfatal myocardial infarction. These findings challenge the prevailing practice of using a sex-neutral LVEF threshold, urging the adoption of female-specific approaches in recognizing, diagnosing, and managing cardiovascular disease.
Read More
Patients with implantable cardioverter defibrillators (ICDs) face a higher risk of anxiety, depression, and PTSD, affecting their overall well-being. A comprehensive meta-analysis of studies reveals the alarmingly prevalent mood disorders among ICD recipients.
Read More
The FDA has granted approval for a 0.5 mg dose of colchicine for high-risk patients with atherosclerotic cardiovascular disease (CVD) or multiple cardiovascular risk factors who have residual inflammatory risk.
Read More
Artificial intelligence (AI) is revolutionizing cardiovascular health prediction, offering the potential for more accurate risk assessments and personalized interventions. Through machine learning algorithms and analysis of medical imaging, AI empowers healthcare professionals to make informed decisions and save lives.
Read More